Acetyl-CoA synthetase 2 enhances tumorigenesis and is indicative of a poor prognosis for patients with renal cell carcinoma

Acetyl-CoA synthetase 2 (ACSS2) is highly expressed in various cancers, whereas ACSS2 expression and function in renal cell carcinoma (RCC) are unknown.

Source: Urologic Oncology: Seminars and Original Investigations - March 1, 2018 Category: Urology & Nephrology Authors: Shaojin Zhang, Juanjuan He, Zhankui Jia, Zechen Yan, Jinjian Yang Tags: Original article Source Type: research